Items of recent pandemic news: Novavax notches some wins; J&J’s vaccine is deprecated; vaccines for young kids will have to wait; the US government is stockpiling antibodies; the implications of Omicron’s (possibly) faster incubation; and more. Plus a frippery. Quotes … Continue reading →
Items of recent pandemic news: Simulating an aerosolized virus particle with 1.3 billion atoms via a supercomputer; the first monoclonal antibody treatment authorized for young children; Omicron may be breaking through natural immunity; and molnupiravir’s tepid affirmation. Plus a frippery. … Continue reading →
Items of recent pandemic news: How the sex of the fetus affects a mother’s immune response to the coronavirus; the prospect for vaccination in ages 5-11; boosters authorized in mix-and-match format; and more. Plus a frippery. Boosters for most everyone … Continue reading →
Items of recent pandemic news: Decisions soon on immunizing kids 5-11 and on boosters for Moderna and J&J; an injectable anti-viral and an oral one; new studies on Delta’s virulence and aerosol transmissibility; plus a frippery. Molnupiravir works The day … Continue reading →
Items of recent pandemic news: Detection in Laotian bats of possible SARS-CoV-2 precursors; Covid-19’s effects on the brain; progress towards an antiviral pill; why the US may fail the next pandemic too; and more. Plus a frippery. Lessons not learned … Continue reading →
Items of recent pandemic news: Auto-antibodies in long Covid; Moderna’s durability benefit over Pfizer; results from Johnson & Johnson’s two-dose trial; Pfizer’s effectiveness in kids 5-11; and who gets a Pfizer booster. Plus a frippery. FDA, CDC committee approve boosters … Continue reading →
Items of recent pandemic news you may have missed: The youngest children are strong spreaders of SARS-CoV-2; all the Covid-19 deaths that did not happen; the case against US booster shots; and more. Plus a frippery. 1. Against boosters The … Continue reading →
Three items of recent pandemic news: Human trials near for an inhalable antiviral; rumors of bad behavior by Google with an infection-tracking and notification app; and the WHO recommends against vaccinating children. Plus a news brief and a frippery. WHO … Continue reading →
Three items of pandemic news: Long Covid in children; an FDA panel confirms an excess of heart inflammation following mRNA vaccination; and how the American tendency to individualism over collectivism hamstrung our pandemic response. Plus news briefs and a frippery. … Continue reading →
Items of recent pandemic news: Moderna’s vaccine works in those 12 to 17 years old; the political nature of college mandates to vaccinate returning students; and a new, fast-spreading variant out of India. Plus news briefs and a frippery. B.1.617.2 … Continue reading →
Herewith three items of recent pandemic news: More studies on mixing vaccine doses; the FDA extends Pfizer’s authorization to ages 12+; and acknowledgement from the CDC that this virus is airborne. Plus news briefs and a frippery. It is indeed … Continue reading →
Belatedly, three items of recent pandemic news: Novavax and the EU; a detailed study of long haulers in the VA health care system; and the imminent authorization of Pfizer’s vaccine for young adolescents. Plus news briefs and a frippery. Authorization … Continue reading →
Herewith three items of pandemic news you may have missed recently: Disparate theories of long Covid; Europe locks in 1.8 billion Pfizer doses; and the troubles attendant upon Russia’s Sputnik V vaccine. Plus news briefs and a frippery. Russia’s Sputnik … Continue reading →
Herewith three items of pandemic news you may have missed recently: Covid-19 can damage the brain without infecting it; what’s up with the blood clots; and the FDA shuts down Emergent’s Baltimore operation. Plus news briefs and a frippery. FDA … Continue reading →
Three items of pandemic news you may have missed recently: Moderna can pack more doses per vial; Emergent’s big mistake; and news on vaccines for kids as young as 12. Plus news briefs and a pair of fripperies. Pfizer is … Continue reading →
